Arch Coal Stock News

Overwhelmed with negative economic news, investors are unsure whether to buy or sell growth stocks. Is it time to take a contrarian approach and buy growth stocks before the bull market returns?

Coal stocks have paused but still lead all other industries so far in 2022 — seemingly bucking analyst predictions that coal is dead. The post Coal Stocks Surge As Energy Crisis Drives Coal Use Towa

Is inflation rising? The answer depends upon how you look at the most recent Consumer Price Index data that was released on Sept.

A rail strike which could have brought key shipments to a standstill, straining the high-inflation economy, seems to have been averted. The post Rail Strike, 'Significant Damage' To Economy Derailed,

In the latest trading session, Arch Resources (ARCH) closed at $131.94, marking a -1.29% move from the previous day.

Coal was meant to be dying. This memo has been missed by Arch's commons which are up 81% over the last year. The company is printing cash and has used this to launch a campaign of outsized dividends t

Arch Resources is trading at very low multiples as coal is a hated and dying business. One of the reasons for its low valuation is likely limited exposure to thermal and less exposure to spot rates.

I love holding mining stocks in my portfolio. Why? Because they can provide beastly performance no matter what the economic environment is like.

Arch Resources (ARCH) closed at $145.58 in the latest trading session, marking a -1.15% move from the prior day.

Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares surged 103.9% to settle at $5.30 on Tuesday. Shares are in low-float territory; the issue has about 15 million shares in its float. NewAge, In

Photronics, Inc. (NASDAQ: PLAB) fell 23% to $16.76. Photronics posted upbeat Q3 results, but issued weak outlook for the current quarter. Cross Timbers Royalty Trust (NYSE: CRT) fell 17.8% to $20.23.

These reports, excerpted and edited by Barron's, were issued recently by investment and research firms. The reports are a sampling of analysts' thinking; they should not be considered the views or rec

TORONTO, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company targeting acute organ inflammation

The booming coal market during 2022 caught many investors by surprise with the extremely strong financial performance of Arch Resources, leading to massive dividends. Despite the dividends declared fo

Stocks continue to trend higher with the S&P 500 trading near a 3-month high. We are bullish and expect more upside into what could be an accelerating market-wide short squeeze.